Cargando…

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis

Several studies reported a potential role of methane producing archaea in the pathophysiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the prevalence of methane positive small intestinal bacterial overgrowth...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Arjun, Shah, Ayesha, Jones, Michael P., Koloski, Natasha, Talley, Nicholas J., Morrison, Mark, Holtmann, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253120/
https://www.ncbi.nlm.nih.gov/pubmed/34190027
http://dx.doi.org/10.1080/19490976.2021.1933313
_version_ 1783717445364613120
author Gandhi, Arjun
Shah, Ayesha
Jones, Michael P.
Koloski, Natasha
Talley, Nicholas J.
Morrison, Mark
Holtmann, Gerald
author_facet Gandhi, Arjun
Shah, Ayesha
Jones, Michael P.
Koloski, Natasha
Talley, Nicholas J.
Morrison, Mark
Holtmann, Gerald
author_sort Gandhi, Arjun
collection PubMed
description Several studies reported a potential role of methane producing archaea in the pathophysiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the prevalence of methane positive small intestinal bacterial overgrowth (SIBO) in IBS and IBD compared with controls. MEDLINE (PubMed) and Embase electronic databases were searched from inception until March 2021 for case-control and prevalence studies reporting SIBO in IBS and IBD. We extracted data from published studies and calculated pooled prevalence of SIBO in IBS or IBD, odds ratios (OR), and 95% CIs, utilizing a random effects model. The final dataset included 17 independent studies assessing the prevalence of methane positive SIBO in 1,653 IBS-patients and 713 controls, and 7 studies assessing the prevalence of methane positive SIBO in 626 IBD-patients and 497 controls, all utilizing breath test for SIBO diagnosis. Prevalence of methane positive SIBO in IBS and IBD was 25.0% (95% CI 18.8–32.4) and 5.6% (95% CI 2.6–11.8), respectively. Methane positive SIBO in IBS was not increased compared to controls (OR = 1.2, 95% CI 0.8–1.7, P = .37) but was significantly more prevalent in IBS-C as compared to IBS-D (OR = 3.1, 95% CI 1.7–5.6, P = .0001). The prevalence of methane-positive SIBO in patients with IBD was 3-fold lower at 7.4% (95% CI 5.4–9.8) compared to 23.5% (95% CI 19.8–27.5) in controls. The prevalence of methane positive SIBO was significantly lower in Crohn’s disease as compared to ulcerative colitis, (5.3%, 95% CI 3.0–8.5 vs. 20.2%, 95% CI 12.8–29.4). This systematic review and meta-analysis suggests methane positivity on breath testing is positively associated with IBS-C and inversely with IBD. However, the quality of evidence is low largely due to clinical heterogeneity of the studies. Thus, causality is uncertain and further studies are required.
format Online
Article
Text
id pubmed-8253120
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-82531202021-07-13 Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis Gandhi, Arjun Shah, Ayesha Jones, Michael P. Koloski, Natasha Talley, Nicholas J. Morrison, Mark Holtmann, Gerald Gut Microbes Review Several studies reported a potential role of methane producing archaea in the pathophysiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the prevalence of methane positive small intestinal bacterial overgrowth (SIBO) in IBS and IBD compared with controls. MEDLINE (PubMed) and Embase electronic databases were searched from inception until March 2021 for case-control and prevalence studies reporting SIBO in IBS and IBD. We extracted data from published studies and calculated pooled prevalence of SIBO in IBS or IBD, odds ratios (OR), and 95% CIs, utilizing a random effects model. The final dataset included 17 independent studies assessing the prevalence of methane positive SIBO in 1,653 IBS-patients and 713 controls, and 7 studies assessing the prevalence of methane positive SIBO in 626 IBD-patients and 497 controls, all utilizing breath test for SIBO diagnosis. Prevalence of methane positive SIBO in IBS and IBD was 25.0% (95% CI 18.8–32.4) and 5.6% (95% CI 2.6–11.8), respectively. Methane positive SIBO in IBS was not increased compared to controls (OR = 1.2, 95% CI 0.8–1.7, P = .37) but was significantly more prevalent in IBS-C as compared to IBS-D (OR = 3.1, 95% CI 1.7–5.6, P = .0001). The prevalence of methane-positive SIBO in patients with IBD was 3-fold lower at 7.4% (95% CI 5.4–9.8) compared to 23.5% (95% CI 19.8–27.5) in controls. The prevalence of methane positive SIBO was significantly lower in Crohn’s disease as compared to ulcerative colitis, (5.3%, 95% CI 3.0–8.5 vs. 20.2%, 95% CI 12.8–29.4). This systematic review and meta-analysis suggests methane positivity on breath testing is positively associated with IBS-C and inversely with IBD. However, the quality of evidence is low largely due to clinical heterogeneity of the studies. Thus, causality is uncertain and further studies are required. Taylor & Francis 2021-06-30 /pmc/articles/PMC8253120/ /pubmed/34190027 http://dx.doi.org/10.1080/19490976.2021.1933313 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Gandhi, Arjun
Shah, Ayesha
Jones, Michael P.
Koloski, Natasha
Talley, Nicholas J.
Morrison, Mark
Holtmann, Gerald
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title_full Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title_fullStr Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title_full_unstemmed Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title_short Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis
title_sort methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253120/
https://www.ncbi.nlm.nih.gov/pubmed/34190027
http://dx.doi.org/10.1080/19490976.2021.1933313
work_keys_str_mv AT gandhiarjun methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT shahayesha methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT jonesmichaelp methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT koloskinatasha methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT talleynicholasj methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT morrisonmark methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis
AT holtmanngerald methanepositivesmallintestinalbacterialovergrowthininflammatoryboweldiseaseandirritablebowelsyndromeasystematicreviewandmetaanalysis